1. Home
  2. CDT vs CISO Comparison

CDT vs CISO Comparison

Compare CDT & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • CISO
  • Stock Information
  • Founded
  • CDT 2019
  • CISO 2015
  • Country
  • CDT United States
  • CISO United States
  • Employees
  • CDT N/A
  • CISO N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • CDT Health Care
  • CISO Technology
  • Exchange
  • CDT Nasdaq
  • CISO Nasdaq
  • Market Cap
  • CDT 10.9M
  • CISO 12.5M
  • IPO Year
  • CDT N/A
  • CISO N/A
  • Fundamental
  • Price
  • CDT $0.11
  • CISO $1.20
  • Analyst Decision
  • CDT
  • CISO
  • Analyst Count
  • CDT 0
  • CISO 0
  • Target Price
  • CDT N/A
  • CISO N/A
  • AVG Volume (30 Days)
  • CDT 34.8M
  • CISO 54.4K
  • Earning Date
  • CDT 11-14-2024
  • CISO 11-18-2024
  • Dividend Yield
  • CDT N/A
  • CISO N/A
  • EPS Growth
  • CDT N/A
  • CISO N/A
  • EPS
  • CDT N/A
  • CISO N/A
  • Revenue
  • CDT N/A
  • CISO $49,253,314.00
  • Revenue This Year
  • CDT N/A
  • CISO $78.76
  • Revenue Next Year
  • CDT N/A
  • CISO N/A
  • P/E Ratio
  • CDT N/A
  • CISO N/A
  • Revenue Growth
  • CDT N/A
  • CISO 7.33
  • 52 Week Low
  • CDT $0.08
  • CISO $0.26
  • 52 Week High
  • CDT $7.83
  • CISO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • CDT 52.44
  • CISO 66.83
  • Support Level
  • CDT $0.08
  • CISO $0.90
  • Resistance Level
  • CDT $0.10
  • CISO $0.92
  • Average True Range (ATR)
  • CDT 0.02
  • CISO 0.11
  • MACD
  • CDT 0.00
  • CISO 0.02
  • Stochastic Oscillator
  • CDT 33.24
  • CISO 89.36

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: